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We have shown that IgG hydrolysed by Schistosoma mansoni schistosomula inhibited various macrophage 
functions, especially phagocytosis and anti-schistosome cytotoxicity. Here we show that a tripeptide, 
Thr289-Lys-Pro29r1 of the second constant domain of human immunogiobulin G (peptide 286-292) 
reproduced the inhibitory effect of a total hydrolysate. Indeed then-glucuronidase release from IgE-anti- 
IgE-stimulated rat and human macrophages decreased and its intracellular IeveI did not rise after a prior 
incubation of the cells with Thr-Lys-Pro (500 nmoVm1). Moreover, the cell migration as well as the 
superoxide anion 0: generation were 50-80’70 reduced by the tripeptide. These results uggest that a single 
peptide set may be responsible for the decrease of the macrophage functions at the early stage of the 
parasite infection in the mammalian host. The pharmacologic properties of this tripeptide are under 
investigation. 
Macrophage inhibitory peptide Human IgG Second constant domain 
1. INTRODUCTION 
IgG, bound onto the surface of Sc~~si~so~~ 
ma~so~i scbistoso~ula, was cleaved by proteases 
secreted by the larvae. This process of binding and 
cleavage of IgG molecules generates peptidic 
fragments, liberated in the larval environment, 
which interfere with various macrophage functions 
[l]. Indeed, it was initially shown that a total IgG 
hydroiysate inhibited the macrophage stimulatjon 
assessed by ~-g~ucuronidase release and 
giucosamine incorporation, and reduced both 
phagocytosis of latex beads and IgE-mediated 
macrophage cytotoxicity against schistosomula 
[2]. The IgG hydrolysate apparently prevented the 
cell stimulation itself, without affecting its viabili- 
ty. IgE-activated macrophages being one of the 
main effector mechanisms involved in the anti- 
schistosome immunity, its inhibition by such pep- 
tides could, at least in part, facilitate host invasion 
by parasites. But more generally, the inhibiting ef- 
fect on the phagocytic activity of the macrophage 
suggests the use of the active peptides as molecules 
with pharmacologic goals. 
In the present study we have demonstrated that 
a tripeptide* from the second constant domain of 
human IgG reproduced the inhibiting effect of a 
totat IgG hydrolysate on several macrophage 
functions. 
2. MATERIALS AND METHODS 
2.1. Preparation of IgG hydrolysate 
* French Patent Application o. 82.12222 filed Juiy 2, 
1982. 
Schistosomula of a Puerto-Rican strain of 
Sc~~s~osoma manson~ were obtained from cer- 
cariae by a mechanical procedure in vitro [3]. The 
larvae were incubated for 16 h at 37°C in MEM 
with 60,~g rat IgG/ml. The absence of bacterial 
contamination was controlled. After elimination 
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of schistosomula by centrifugation, the hydrolysis 
was stopped by heating the supernatant 5 min at 
100°C. 
2.2. Metabolic and functional parameters 
The extracellular release of the lysosomal ,& 
glucuronidase, induced in IgE-stimulated cells by a 
further 30 min incubation with anti-IgE, was 
measured as in [4]. 
Superoxide anion 02 generation was quantified 
by the reduction of cytochrome c according to [5] 
as modified in [6] with IgE-stimulated cells trig- 
gered for 120 min by anti-IgE-opsonized zymosan 
in phenol-red free Hank’s balanced salt solution 
(HW). 
Specific IgE-dependent macrophage cytotoxicity 
against schistosomula was performed as in [7] by 
a 6 h-preincubation of the effector cells with S. 
mansoni-immune rat serum. 
2.3. Cell viability 
In all cases, >90% living cells were observed in 
the presence or absence of IgG peptides, estimated 
by the trypan blue exclusion test and the fluores- 
cein diacetate method [S]. 
2.4. Macrophage triggering by IgE 
For human alveolar macrophages, the free lung 
cells were recovered after informed consent from 
non-atopic patients, by bronchoalveolar lavage 
performed under fiberoptic bronchoscopy. The 
cell pellets of centrifuged lavage fluids, consisting 
of 93% alveolar macrophages and 7% lym- 
phocytes, were resuspended in MEM with 10% 
foetal calf serum, and incubated for a 2 h- 
adherence phase. After removal of unadherent 
cells, the macrophages were 98% pure, and further 
incubated overnight in the same medium. 
Rat peritoneal macrophages were purified to 
95% by adherence, for 2 h, and incubated over- 
night like human alveolar macrophages. 
Both cell populations were treated at 37°C with 
IgG peptides (500 nmol/ml) for 30 min, washed, 
and then exposed to IgE triggering [6,9]: a first 
30 min-incubation at 37°C in 10 pg IgE/ml HW 
was followed, after washing, by a second 30 min- 
period in 10~1 anti-IgE antibody/ml HW. Super- 
natants were recovered, and cells lysed with Triton 
X-100 0.1% in Tris-MgClz 0.01 M (pH 7.4) for 
extra- and intracellular lysosomal enzyme assay. 
12 
2.5. Macrophage chemotaxis 
Rat peritoneal macrophages were purified to 
95% by a 2 h-adherence phase, incubated for 
30 min with IgG peptides, washed, and recovered 
by scrapping. The macrophage-enriched popula- 
tion was adjusted to lo6 cells/ml MEM with 10% 
foetal calf serum, and used for chemotaxis. 
Macrophage migration was assessed at 37°C for 
2 h in a 48-well microchemotaxis assembly 
(Neuroprobe Corporation, Bethesda MD), with a 
5 pm porosity polycarbonate filter (Nuclepore 
Corporation, Pleasanton CA) [lo] and 10% 
zymosan activated normal rat serum in MEM as 
chemoattractant. The filter was stained with Giem- 
sa, and chemotaxis was quantified by counting and 
averaging the macrophages that migrated com- 
pletely through the filter, and present on its lower 
surface. 
2.6. Peptides 
Peptide synthesis was performed by the solid 
phase method [l l] in an automated Beckman syn- 
thesizer Model 990B as in [12]. N-Boc-amino acids 
were used and trifunctional amino acids were pro- 
tected as N-Boc-Arg (Tos), N-Boc-Lys (Z) and N- 
Boc-Thr (Bal). Asn was incorporated with 
DCC/HOBT coupling as proposed in [13]. The 
protected peptidyl-resins were cleaved by a 1 h HF 
treatment in the presence of anisole. The crude 
peptides were first purified by gel filtration (GlO, 
Pharmacia) followed by preparative reverse-phase 
chromatography (Lobar CS, Merck). The purified 
peptides were checked by analytical HPLC, TLC 
in two different solvent systems and amino-acid 
analysis of their acid hydrolysates. 
3. RESULTS 
When the rat macrophages were incubated with 
various peptides of the second constant domain of 
human IgG before IgE triggering, a decrease of the 
selective lysosomal enzyme release (table 1) and of 
the chemotaxis (table 2) could be observed. Thr-- 
Lys-Pro exhibited the maximum inhibitory effect. 
In contrast, the hexapeptide Asn-Ala-Lys-Thr-- 
Lys-Pro was without effect on the macrophage ac- 
tivity, while the penta- and tetrapeptides howed 
intermediate activity. Furthermore, the tetrapep- 
tide Tuftsin as well as its competitive inhibiting 
tripeptide Lys-Pro-Arg, had no effect on the trig- 
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Release and intracellular level of @-glucuronidase from IgE-anti-IgE-stimulated rat peritoneal macrophages following 
incubation with IgG peptides of the second constant domain 
First incubation Second 
incubation 
N” Enzyme % In- ,Intracellularb 
releaseb hibition level 
I@ 
IgE + Asn-Ala-Lys-Thr-Lys-ProC 
IgE + Ala-Lys-Thr-Lys-Pro 
IgE + Lys-Thr-Lys-Pro 
IgE + Thr-Lys-Pro 
IgE + Tuftsin: Thr-Lys-Pro-Arg 
IgE + Lys-Pro-Arg 
IgE + IgG hydrolysate 
HW 
Anti-IgE 
Anti-IgE 
Anti-IgE 
Anti-IgE 
Anti-IgE 
Anti-IgE 
Anti-IgE 
Anti-IgE 
HW 
15 12.6 + 0.9 0 241 k 13 
2 15.6 k 5.8 - 260 f 32 
4 11.1 + 3.4 15 222 + 33 
10 10.6 + 3.1 20 213 + 27 
13 5.4 + 0.4 73 174 + 16 
2 10.6 + 0.2 20 244 + 12 
5 10.3 + 0.8 23 247 t- 13 
7 6.9 k 0.7 58 185 k 16 
15 2.8 f 0.4 100 204 + 14 
a Number of experiments in triplicate 
b nmoles of hydrolysed substrate/lo6 cells (mean + SEM) 
’ All peptides were used at 500 nmol/ml 
Table 2 Table 3 
Chemotaxis of rat peritoneal macrophages after 
incubation with peptides of the second constant domain 
of IgG 
Superoxide anion generation by IgE-anti-IgE-triggered 
rat peritoneal macrophages in the presence of 
IgG-peptidesa 
Macrophages pre-incubated 
with 
Number % In- 
of cellsa hibition 
Preincubation with Superoxide % In- 
anionb hibition 
HW 44.1 k 8.0 - 
+Asn-Ala-Lys-Thr-Lys-Prob 50.1 + 8.9 - 
+ Ala-Lys-Thr-Lys-Pro 27.8 + 2.7 37 
+ Lys-Thr-Lys-Pro 25.2 + 4.0 43 
+ Thr-Lys-Pro 6.6 + 2.7 85 
a Mean of 16 optic fields of experiments made in 
triplicate 
b All peptides were used at the concentration of 
500 nmol/ml 
gering by IgE. Thr-Lys-Pro exhibited the same 
inhibitory effect on the superoxide anion Or 
generation by rat macrophages, and reproduced 
the inhibition observed with an hydrolysate of IgG 
by schistosomulum-secreted proteases (table 3). 
This last observation may be related to the reduc- 
tion of the IgE-dependent cytotoxicity expressed 
by rat macrophages against schistosome larvae 
after incubation with the tripeptide: in such condi- 
tions, macrophages exhibited a 38% decrease in 
the in vitro killing of schistosomula. 
Medium alone 
IgG hydrolysate 
Tripeptide (Thr-Lys-Pro)c 
71.7 * 10.4 - 
19.3 + 9.1 73 
35.4 k 1.06 51 
a Triggering signal given by IgE (30 min) followed by 
anti-IgE opsonized zymosan 
b nmoles of SOD-inhibitable reduced cytochrome c/lo7 
cells 
’ Used at 500 nmol/ml 
Besides its activity on rat macrophages, the same 
tripeptide proved to be inhibitory also for human 
alveolar macrophages during the interaction with 
IgE, either as myeloma protein or as allergen- 
specific antibody (table 4). For both rat and 
human macrophages, in addition to the inhibitory 
effects on enzyme exocytosis, the intracellular 
P-glucuronidase, in the presence of the tripeptide 
Thr-Lys-Pro, remained at the level of unsti- 
mulated cells when compared to optimally trig- 
gered phagocytes. 
13 
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Release of ,&glucuronidase from IgE/anti-IgE and allergen-stimulated human alveolar macrophages after incubation 
with an IgG tripeptide of the second constant domain 
First incubation Second Enzyme 
incubation releasea 
IgE 
+ Thr-Lys-Prob 
HW 
Anti-IgE 
Anti-IgE 
HW 
87.5 + 8.0 0 1757.5 + 6.8 
37.5 f 3.0 71 1692.5 + 37.0 
17.5 * 3.0 - 1668.2 f 16.0 
Serum from asthmatic patient 
+ Thr-Lys-Pro 
HW 
Allergek 
Allergen 
HW 
% In- Intracellular 
hibition level 
35.0 * 0.5 0 875.0 f 5.0 
22.5 f 3.5 63 831.5 + 7.5 
15.0 * 0.5 - 781.5 k 40.5 
a Results expressed as nmol substrate/lo6 cells 
b Peptide used at 500 nmol/ml 
’ Allergen (Dermatophagoides pteronyssinus) used at 100 ng HW/ml 
4. DISCUSSION 
Here we show that peptides of the second con- 
stant domain of human IgG molecules strongly in- 
hibited various macrophage activities during 
IgE-anti-IgE stimulation and, more particularly, 
the release of lysosomal enzymes such as ,8- 
glucuronidase, and the superoxide anion 02 
generation. The cell migration was also significant- 
ly reduced. The inhibitory effect of the tripeptide 
Thr-Lys-Pro decreased upon the addition of 
amino acids to the NH2 position (Asnzs6, A1a2g7 
and Lys2&, or to the COOH position (Arg292) of 
the IgG sequence. The peptide apparently in- 
terfered with the stimulation process itself, without 
affecting the basal cell activity. Indeed this effect 
could not be related to any direct toxic action on 
the cells, since appropriate controls clearly showed 
that macrophage viability was not altered. The 
tetrapeptide Tuftsin (Thr-Lys-Pro-Arg), known 
to increase the macrophage functions, had neither 
activating nor inhibiting effect on the rat 
macrophages when added during the IgE-anti-IgE 
triggering. This could be related to the high effi- 
ciency of the IgE-anti-IgE reaction to stimulate 
the macrophage [14]. In addition, Lys-Pro-Arg, 
which is a competitive inhibitor of Tuftsin [15], 
was without effect in these triggering and in- 
hibitory processes. Therefore, to interfere with the 
macrophage activity, Thr-Lys-Pro probably does 
not exert its action through the Tuftsin receptors 
14 
of the cells, and may use cellular targets distinct 
from these reported in the Tuftsin system. 
Moreover, Thr-Lys-Pro was never described as 
an inhibitor of Tuftsin. 
Of particular interest was the interaction of this 
peptide with the triggering of human alveolar 
macrophages by the serum of asthmatic patients 
which was shown to induce a rapid and strong IgE- 
dependent stimulation of the cell metabolism and 
secretory functions upon the addition of specific 
allergens [6,16]. 
Though the effect of this tripeptide on the 
macrophage activity resembles that described for 
the whole hydrolysate of IgG by parasitic pro- 
teases, it is not excluded that other peptides from 
the IgG molecule could play such an inhibitory 
role, and their identification is presently under in- 
vestigation. Nevertheless, the COOH-terminal 
proline of the tripeptide suggests the need of pro- 
lidase activity among the proteases ecreted by the 
young larval stage of schistosome. Indeed, some of 
them exhibit prolidase and collagenase specificities 
VI. 
An immunopharmacologic study of this tripep- 
tide and of its analogues is underway. 
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